MAAS is an acronym used in several different fields, and the meaning depends on context. The two most common uses are the Mindful Attention Awareness Scale, a psychological questionnaire that measures how mindful you are in everyday life, and the Motor Activity Assessment Scale, a clinical tool used in intensive care units to gauge how sedated or agitated a patient is. A third, less commonly searched meaning is the Manchester Asthma and Allergy Study, a long-running birth cohort study in the UK.
Mindful Attention Awareness Scale
The Mindful Attention Awareness Scale is a 15-item questionnaire developed by psychologists Kirk Brown and Richard Ryan in 2003. It measures how often you naturally pay attention to what’s happening in the present moment rather than operating on autopilot. Unlike many mindfulness tools that focus on meditation practice, the MAAS captures something broader: your general tendency to notice your thoughts, feelings, and surroundings as you go about your day.
Each of the 15 items describes a common experience of being mentally “checked out.” For example, you might be asked how often you find yourself doing things without paying attention, or how frequently you eat without noticing what you’re tasting. You rate each item on a 6-point scale ranging from “almost always” (scored 1) to “almost never” (scored 6). Your final score is simply the average of all 15 responses, so it falls between 1 and 6. Higher scores mean you tend to be more present and aware in daily life.
The scale has strong psychometric backing. Internal consistency, a measure of how reliably the questions capture the same underlying trait, ranges from .82 to .93 across different populations. Studies in groups as diverse as U.S. college students, military personnel, and Chinese adolescents have confirmed that the MAAS consistently measures a single core trait: dispositional mindfulness. People who score higher on the MAAS tend to report lower levels of stress, depression, aggression, and impulsive behavior. The scale also picks up meaningful differences in well-being beyond what self-control and self-esteem measures capture on their own, which suggests mindfulness contributes something unique to mental health.
Researchers, therapists, and wellness programs use the MAAS to track changes in mindfulness over time, often before and after meditation training or cognitive therapy. A shorter 6-item version also exists for situations where a quick assessment is needed.
Motor Activity Assessment Scale (ICU Use)
In critical care medicine, MAAS stands for the Motor Activity Assessment Scale, a bedside tool nurses use to evaluate how sedated or agitated a patient is. This matters most for patients on mechanical ventilation, where too much sedation can delay recovery and too little can lead to dangerous agitation, such as a patient pulling out breathing tubes.
The scale runs from 0 to 6, with each score tied to specific observable behaviors:
- 0: Unresponsive, even to painful stimulation
- 1: Opens eyes or moves only in response to pain
- 2: Opens eyes or moves in response to voice
- 3: Calm and cooperative
- 4: Restless but still cooperative, follows commands
- 5: Agitated, may try to get out of bed, temporarily responds to requests but reverts back
- 6: Dangerously agitated, pulling at tubes or lines, thrashing, does not follow commands
A score of 3 is generally the target: the patient is calm, comfortable, and able to interact. Scores of 0 or 1 suggest oversedation, while 5 or 6 signal a need for intervention to protect the patient. The MAAS is one of several sedation scales used in ICUs alongside the Richmond Agitation-Sedation Scale and the Ramsay Sedation Scale. All four major sedation scales perform comparably, and the choice between them often comes down to institutional preference and nursing familiarity.
Manchester Asthma and Allergy Study
The Manchester Asthma and Allergy Study is a prospective birth cohort study based in the UK that tracks the development of asthma and allergies in children considered high-risk because both parents have allergic conditions. Families were recruited before birth and randomly assigned to either a strict dust mite allergen avoidance regimen or standard household conditions. The study’s central question is whether reducing allergen exposure during pregnancy and early infancy can prevent sensitization and, ultimately, asthma.
Early findings confirmed that a low-allergen environment could be achieved and maintained through pregnancy and the first year of life. The study built on evidence that early exposure to dust mite allergens may be a critical trigger for the immune system to develop allergic sensitivity. MAAS has been running for over two decades and has contributed to the broader understanding of how childhood environment shapes lifelong respiratory health.